Cargando…

First person – Jenny Vermeer and Jonathan lent

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406321/
http://dx.doi.org/10.1242/dmm.046292
_version_ 1783567397292081152
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia.
format Online
Article
Text
id pubmed-7406321
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-74063212020-08-06 First person – Jenny Vermeer and Jonathan lent Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia. The Company of Biologists Ltd 2020-07-30 /pmc/articles/PMC7406321/ http://dx.doi.org/10.1242/dmm.046292 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Jenny Vermeer and Jonathan lent
title First person – Jenny Vermeer and Jonathan lent
title_full First person – Jenny Vermeer and Jonathan lent
title_fullStr First person – Jenny Vermeer and Jonathan lent
title_full_unstemmed First person – Jenny Vermeer and Jonathan lent
title_short First person – Jenny Vermeer and Jonathan lent
title_sort first person – jenny vermeer and jonathan lent
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406321/
http://dx.doi.org/10.1242/dmm.046292